{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:55:42Z","timestamp":1793310942062,"version":"4.5.0"},"reference-count":140,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.bbmt.2016.12.632","type":"journal-article","created":{"date-parts":[[2016,12,27]],"date-time":"2016-12-27T15:46:00Z","timestamp":1482853560000},"page":"388-397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"title":["Neurologic Complications after Allogeneic Hematopoietic Stem Cell Transplantation"],"prefix":"10.1016","volume":"23","author":[{"given":"Enrico","family":"Maffini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moreno","family":"Festuccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Brunello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Boccadoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Giaccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetto","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2016.12.632_bib0010","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/bmt.2014.55","article-title":"Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation","volume":"49","author":"Passweg","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0015","doi-asserted-by":"crossref","first-page":"9387","DOI":"10.1200\/JCO.2005.02.0057","article-title":"Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasia","volume":"23","author":"Tauro","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0020","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1038\/bmt.2013.67","article-title":"To transplant or not: a dilemma for treatment of elderly AML patients in the twenty-first century","volume":"48","author":"Ustun","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0025","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.bbmt.2009.07.013","article-title":"Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation","volume":"15","author":"Barba","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0030","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/sj.bmt.1702140","article-title":"Neuropathological findings after bone marrow transplantation: an autopsy study of 180 cases","volume":"25","author":"Bleggi-Torres","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0035","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.bbmt.2007.07.013","article-title":"Central nervous system complications after allogeneic hematopoietic stem cell transplantation: incidence, manifestations, and clinical significance","volume":"13","author":"Siegal","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0040","first-page":"393","article-title":"Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporine","volume":"8","author":"Reece","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0045","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1399-0012.2009.01181.x","article-title":"Influence of CYP3A5 and ABCB1 gene polymorphisms on calcineurin inhibitor-related neurotoxicity after hematopoietic stem cell transplantation","volume":"24","author":"Yanagimachi","year":"2010","journal-title":"Clin Transplant"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0050","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/ana.410400511","article-title":"Cyclosporine induces neuronal apoptosis and selective oligodendrocyte death in cortical cultures","volume":"40","author":"McDonald","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0055","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1161\/01.HYP.18.4.458","article-title":"Cyclosporine causes sympathetically mediated elevations in arterial pressure in rats","volume":"18","author":"Morgan","year":"1991","journal-title":"Hypertension"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0060","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S0140-6736(84)91556-3","article-title":"Association between cyclosporin neurotoxicity and hypomagnesaemia","volume":"2","author":"Thompson","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0065","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJM198710013171404","article-title":"Central nervous system toxicity after liver transplantation: the role of cyclosporine and cholesterol","volume":"317","author":"de Groen","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0070","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1399-0012.2005.00357.x","article-title":"Endothelin-1 plasma levels and hypertension in cyclosporine-treated renal transplant patients","volume":"19","author":"Cauduro","year":"2005","journal-title":"Clin Transplant"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0075","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/PL00005622","article-title":"Changes in the bioenergetic state of rat hippocampus during 2.5\u2009min of ischemia, and prevention of cell damage by cyclosporin A in hyperglycemic subjects","volume":"114","author":"Folbergrov\u00e1","year":"1997","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0080","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1016\/S0021-9258(19)50676-7","article-title":"Modulation of the mitochondrial permeability transition pore: effect of protons and divalent cations","volume":"267","author":"Bernardi","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0085","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3174\/ajnr.A0928","article-title":"Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features","volume":"29","author":"Bartynski","year":"2008","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0090","doi-asserted-by":"crossref","first-page":"467-472","DOI":"10.1097\/00007890-200002270-00001","article-title":"Immunosuppressive-associated leukoencephalopathy in organ transplant recipients","volume":"69","author":"Singh","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0095","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/pbc.21688","article-title":"Encephalopathy syndrome in children with hemato-oncological disorders is not always posterior and reversible","volume":"51","author":"Lucchini","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0100","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/pbc.21211","article-title":"In cyclosporine-induced neurotoxicity, is tacrolimus an appropriate substitute or is it out of the frying pan and into the fire?","volume":"50","author":"Ayas","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0105","first-page":"3175","article-title":"Neurologic complications of FK 506","volume":"23","author":"Eidelman","year":"1991","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0110","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/ajh.23402","article-title":"Tacrolimus-associated posterior reversible encephalopathy syndrome in hematopoietic allogeneic stem cell transplantation","volume":"88","author":"Hammerstrom","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0115","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1200\/JCO.2013.53.0808","article-title":"Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia","volume":"32","author":"Bhojwani","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0120","doi-asserted-by":"crossref","first-page":"E77","DOI":"10.3174\/ajnr.A2191","article-title":"A case of low-dose oral methotrexate-induced reversible neurotoxicity","volume":"31","author":"Paudyal","year":"2010","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0125","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.bbmt.2013.10.028","article-title":"Risk of seizures in children receiving busulphan-containing regimens for stem cell transplantation","volume":"20","author":"Caselli","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0130","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1592\/phco.28.12.1502","article-title":"Optimal prevention of seizures induced by high-dose busulfan","volume":"28","author":"Eberly","year":"2008","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0135","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.bbmt.2010.04.003","article-title":"Toxic leukoencephalopathy following fludarabine-associated hematopoietic cell transplantation","volume":"17","author":"Beitinjaneh","year":"2011","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0140","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.clon.2006.11.003","article-title":"Ifosfamide encephalopathy","volume":"19","author":"Ajithkumar","year":"2007","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0145","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1054\/bjoc.1999.0917","article-title":"Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature","volume":"82","author":"Pelgrims","year":"2000","journal-title":"Brit J Cancer"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0150","first-page":"845","article-title":"Headache, circumoral paresthesia, and facial flushing associated with high-dose carmustine infusion","volume":"19","author":"Woo","year":"1997","journal-title":"BMT"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0155","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1200\/JCO.1989.7.2.179","article-title":"Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's disease","volume":"7","author":"Jagannath","year":"1989","journal-title":"JCO"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0160","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.tox.2011.12.005","article-title":"Cytarabine induced cerebellar neuronal damage in juvenile rat: correlating neurobehavioral performance with cellular and genetic alterations","volume":"293","author":"Patel","year":"2012","journal-title":"Toxicology"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0165","first-page":"1014","article-title":"High-dose cytarabine neurotoxicity: MR findings during the acute phase","volume":"14","author":"Vaughn","year":"1993","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0170","first-page":"77","article-title":"Peripheral neuropathy following high-dose etoposide and autologous bone marrow transplantation","volume":"13","author":"Imrie","year":"1994","journal-title":"BMT"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0175","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00277-012-1601-4","article-title":"Etoposide-induced posterior reversible encephalopathy syndrome","volume":"92","author":"Khanal","year":"2013","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0180","first-page":"1363","article-title":"Targeted therapy and progressive multifocal leukoencephalopathy (PML): PML in the era of monoclonal antibody therapies]","volume":"65","author":"Takao","year":"2013","journal-title":"Brain Nerve"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0185","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-201781","article-title":"Progressive multifocal leukoencephalopathy in a patient with chronic lymphocytic leukaemia treated with alemtuzumab","volume":"2014","author":"Isidoro","year":"2014","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0190","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1182\/blood-2008-10-186999","article-title":"Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project","volume":"113","author":"Carson","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0195","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1200\/JCO.2014.59.1586","article-title":"Bispecific T-cell engager (BiTE) antibody construct blinatumomab for the treatment of patients with relapsed\/refractory non-Hodgkin lymphoma: final results from a phase I study","volume":"34","author":"Goebeler","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0200","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/MPH.0000000000000521","article-title":"Sorafenib-induced posterior reversible encephalopathy syndrome in a child with FLT3-ITD-positive acute myeloid leukemia","volume":"38","author":"Tavil","year":"2016","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0205","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1188\/16.CJON.305-308","article-title":"Early recognition and management of posterior reversible encephalopathy syndrome: a newly recognized complication in patients receiving tyrosine kinase inhibitors","volume":"20","author":"Przybylyski","year":"2016","journal-title":"Clin J Oncol Nurs"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0210","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1136\/jnnp.2004.059824","article-title":"Aciclovir-induced posterior leucoencephalopathy","volume":"76","author":"Mahad","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0215","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/ana.410390326","article-title":"Cytosine arabinoside and amphotericin B-induced parkinsonism","volume":"39","author":"Kulkantrakorn","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0220","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1086\/588844","article-title":"Hallucinations during voriconazole therapy","volume":"47","author":"Zonios","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0225","doi-asserted-by":"crossref","first-page":"R264","DOI":"10.1186\/cc13094","article-title":"Cefepime neurotoxicity in the intensive care unit: a cause of severe, underappreciated encephalopathy","volume":"17","author":"Fugate","year":"2013","journal-title":"Crit Care"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0230","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/jac\/45.1.5","article-title":"Neurotoxicity of carbapenem antibiotics: consequences for their use in bacterial meningitis","volume":"45","author":"Norrby","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0235","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00415-009-5340-y","article-title":"Early-onset probable linezolid-induced encephalopathy","volume":"257","author":"Fletcher","year":"2010","journal-title":"J Neurol"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0240","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1016\/j.ijid.2008.03.006","article-title":"Cerebellar ataxia following prolonged use of metronidazole: case report and literature review","volume":"12","author":"Patel","year":"2008","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0245","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1177\/08830738060210051201","article-title":"Metronidazole: newly recognized cause of autonomic neuropathy","volume":"21","author":"Hobson-Webb","year":"2006","journal-title":"J Child Neurol"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0250","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1212\/WNL.43.8.1619-a","article-title":"Ciprofloxacin-induced complex partial status epilepticus manifesting as an acute confusional state","volume":"43","author":"Isaacson","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0255","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1200\/JCO.2010.33.9119","article-title":"Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years","volume":"29","author":"Syrjala","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0260","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/j.ejca.2007.06.005","article-title":"Case-referent comparison of cognitive functions in patients receiving haematopoietic stem-cell transplantation for haematological malignancies: two-year follow-up results","volume":"43","author":"Harder","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0265","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1212\/01.WNL.0000046522.38465.79","article-title":"Prospective evaluation of neurological complications after allogeneic bone marrow transplantation","volume":"60","author":"Sostak","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0270","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1177\/0269216309106872","article-title":"Modafinil for attentional and psychomotor dysfunction in advanced cancer: a double-blind, randomised, cross-over trial","volume":"23","author":"Lundorff","year":"2009","journal-title":"Palliat Med"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0275","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/pon.1133","article-title":"Cognitive-behavioral management of chemotherapy-related cognitive change","volume":"16","author":"Ferguson","year":"2007","journal-title":"Psychooncology"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0280","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/2110-5820-3-15","article-title":"Understanding brain dysfunction in sepsis","volume":"3","author":"Sonneville","year":"2013","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0285","first-page":"769","article-title":"Intrathecal administration of morphine, but not small doses, induced spastic paraparesis after a noninjurious interval of aortic occlusion in rats","volume":"96","author":"Kakinohana","year":"2003","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0290","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/sj.bmt.1701782","article-title":"Opportunistic CNS infection after bone marrow transplantation","volume":"23","author":"Maschke","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0295","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1212\/01.wnl.0000247038.43228.17","article-title":"Spectrum and prognosis of neurologic complications after hematopoietic transplantation","volume":"67","author":"Denier","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0300","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/clinids\/19.3.402","article-title":"Brain abscess following marrow transplantation: experience at the Fred Hutchinson Cancer Research Center, 1984-1992","volume":"19","author":"Hagensee","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0305","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1053\/crad.1999.0200","article-title":"CT and MRI manifestations of central nervous system infection following allogeneic bone marrow transplantation","volume":"54","author":"Coley","year":"1999","journal-title":"Clin Radiol"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0310","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/sj.bmt.1703812","article-title":"Central nervous system aspergillosis in allogeneic stem cell transplant recipients","volume":"31","author":"Jantunen","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0315","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1086\/503427","article-title":"Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis","volume":"42","author":"Pfeiffer","year":"2006","journal-title":"Clin Inf Dis"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0320","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0325","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1182\/blood-2005-02-0733","article-title":"Improved outcome in central nervous system aspergillosis, using voriconazole treatment","volume":"106","author":"Schwartz","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0330","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3201\/eid1507.090043","article-title":"Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure","volume":"15","author":"Howard","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0335","first-page":"177","article-title":"Candida infections in bone marrow transplant recipients","volume":"8","author":"Verfaillie","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0340","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1365-2141.2005.05749.x","article-title":"Management of intracranial fungal infections in patients with haematological malignancies","volume":"131","author":"Mattiuzzi","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0345","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0732-8893(97)00192-2","article-title":"National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: Frequency of occurrence and antifungal susceptibility in the SCOPE program","volume":"30","author":"Pfaller","year":"1998","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0350","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1212\/WNL.0b013e3182a95871","article-title":"Culture-negative Candida meningitis diagnosed by detection of Candida mannan antigen in CSF","volume":"81","author":"Biesbroek","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0355","doi-asserted-by":"crossref","first-page":"e1-50","DOI":"10.1093\/cid\/civ1194","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0360","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/1469-0691.12566","article-title":"Mucormycosis: from the pathogens to the disease","volume":"20 Suppl 6","author":"Binder","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0365","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1093\/cid\/cir885","article-title":"Combination therapy for mucormycosis: why, what and how?","volume":"54 Suppl 1","author":"Spellberg","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0370","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/bmb\/ldh043","article-title":"Cryptococcal meningitis","volume":"72","author":"Bicanic","year":"2005","journal-title":"Br Med Bull"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0375","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0380","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1034\/j.1399-3062.2002.01016.x","article-title":"Incidence of histoplasmosis following allogeneic bone marrow transplant or solid organ transplant in a hyperendemic area","volume":"4","author":"Vail","year":"2002","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0385","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1086\/521259","article-title":"Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America","volume":"45","author":"Wheat","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0390","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1086\/497596","article-title":"Coccidioidal meningitis","volume":"42","author":"Johnson","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0395","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/tid.12372","article-title":"Diagnosis, treatment, and outcomes of coccidioidomycosis in allogeneic stem cell transplantation","volume":"17","author":"Mendoza","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0400","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s00277-012-1406-5","article-title":"Toxoplasmosis after allogeneic stem cell transplantation: a single centre experience","volume":"91","author":"Busemann","year":"2012","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0405","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1086\/595709","article-title":"Diagnosis of toxoplasmosis after allogeneic stem cell transplantation: results of DNA detection and serological techniques","volume":"48","author":"Fricker-Hidalgo","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0410","article-title":"A systematic review and meta-analysis of the relative efficacy and safety of treatment regimens for HIV-associated cerebral toxoplasmosis: is trimethoprim-sulfamethoxazole a real option?","author":"Hernandez","year":"2016","journal-title":"HIV Med"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0415","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3324\/haematol.2010.029876","article-title":"Viral encephalitis after allogeneic stem cell transplantation: a rare complication with distinct characteristics of different causative agents","volume":"96","author":"Schmidt-Hieber","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0420","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/bmt.2015.76","article-title":"Human herpesvirus-6 encephalitis after allogeneic hematopoietic cell transplantation: what we do and do not know","volume":"50","author":"Ogata","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0425","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.bbmt.2012.04.016","article-title":"Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis","volume":"18","author":"Hill","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0430","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/jmv.24340","article-title":"HHV-6 encephalitis may complicate the early phase after allogeneic hematopoietic stem cell transplantation: detection by qualitative multiplex PCR and subsequent quantitative real-time PCR","volume":"88","author":"Inazawa","year":"2016","journal-title":"J Med Virol"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0435","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/bmt.2010.35","article-title":"CMV central nervous system disease in stem-cell transplant recipients: an increasing complication of drug-resistant CMV infection and protracted immunodeficiency","volume":"45","author":"Reddy","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0440","first-page":"78","article-title":"Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantation","volume":"91","author":"Ljungman","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0445","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1086\/346240","article-title":"Ganciclovir-resistant cytomegalovirus disease after allogeneic stem cell transplantation: pitfalls of phenotypic diagnosis by in vitro selection of an UL97 mutant strain","volume":"187","author":"Hamprecht","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0450","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00007890-198001000-00010","article-title":"Varicella-zoster virus infection after marrow transplantation for aplastic anemia or leukemia","volume":"29","author":"Atkinson","year":"1980","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0455","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.bbmt.2014.06.002","article-title":"Varicella-zoster reactivation after allogeneic stem cell transplantation without routine prophylaxis: the incidence remains high","volume":"20","author":"Blennow","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0460","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/sj.bmt.1702190","article-title":"Varicella-zoster infection after allogeneic bone marrow transplantation: incidence, risk factors and prevention with low-dose aciclovir and ganciclovir","volume":"25","author":"Steer","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0465","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/bmt.2008.386","article-title":"Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia","volume":"43","author":"Styczynski","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0470","first-page":"57A","article-title":"Herpes simplex virus infections of the central nervous system: encephalitis and meningitis, including Mollaret's","volume":"11 Suppl 2","author":"Tyler","year":"2004","journal-title":"Herpes"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0475","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/jemt.1070320405","article-title":"Progressive multifocal leukoencephalopathy: a review of the pathology and pathogenesis","volume":"32","author":"Aksamit","year":"1995","journal-title":"Microsc Res Tech"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0480","first-page":"241","article-title":"B cells and progressive multifocal leukoencephalopathy: search for the missing link","volume":"19","author":"Durali","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0485","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1212\/WNL.0b013e31828c2fa1","article-title":"PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section","volume":"80","author":"Berger","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0490","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/sj.bmt.1704293","article-title":"West Nile virus encephalitis causing fatal CNS toxicity after hematopoietic stem cell transplantation","volume":"33","author":"Reddy","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0495","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1083-8791(03)00102-2","article-title":"Adenovirus infection in hematopoietic stem cell transplantation: effect of ganciclovir and impact on survival","volume":"9","author":"Bruno","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0500","first-page":"809","article-title":"Tuberculosis in bone marrow transplant recipients: report of two cases and review of the literature","volume":"18","author":"Martino","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0505","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s100960000343","article-title":"Listeriosis in recipients of allogeneic bone marrow transplants from unrelated donors","volume":"19","author":"Girmenia","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0510","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.patbio.2014.04.001","article-title":"Diagnosis and management of nocardiosis after bone marrow stem cell transplantation in adults: lack of lymphocyte recovery as a major contributing factor","volume":"62","author":"Mansi","year":"2014","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0515","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/sj.bmt.1702166","article-title":"Diagnosis and management of subdural haematoma complicating bone marrow transplantation","volume":"25","author":"Colosimo","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0520","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1212\/WNL.46.4.1004","article-title":"Neurologic complications of autologous and allogeneic bone marrow transplantation in patients with leukemia: a comparative study","volume":"46","author":"Graus","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0525","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1182\/blood.V122.21.3322.3322","article-title":"Intracranial hemorrhage and mortality in 1461 patients after allogeneic hematopoietic stem cell transplantation for 6-year follow-up: study of 44 cases","volume":"122","author":"Zhang","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0530","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1212\/WNL.58.9.1367","article-title":"Emergency craniotomy in patients worsening due to expanded cerebral hematoma: to what purpose?","volume":"58","author":"Rabinstein","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0535","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1053\/bbmt.2001.v7.pm11302549","article-title":"Secondary failure of platelet recovery after hematopoietic stem cell transplantation","volume":"7","author":"Bruno","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0540","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3324\/haematol.2012.069559","article-title":"Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients","volume":"98","author":"Labrador","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0545","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/00007890-200211150-00018","article-title":"Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients","volume":"74","author":"Pihusch","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0550","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/brain\/124.5.1043","article-title":"Stroke after bone marrow transplantation: frequency, aetiology and outcome","volume":"124(Pt 5)","author":"Coplin","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0555","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/rheumatology\/keg025","article-title":"Polymyositis as a manifestation of chronic graft-versus-host disease","volume":"42","author":"Stevens","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0560","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/thorax.56.1.82","article-title":"Myositis-associated graft-versus-host-disease presenting as respiratory muscle weakness","volume":"56","author":"Stephenson","year":"2001","journal-title":"Thorax"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0565","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.intimp.2005.11.016","article-title":"The role of high-dose immune globulin intravenous in the treatment of dermatomyositis","volume":"6","author":"Dalakas","year":"2006","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0570","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/sj.bmt.1701575","article-title":"Myasthenia gravis and polymyositis as manifestations of chronic graft-versus-host-disease","volume":"23","author":"Tse","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0575","first-page":"474512","article-title":"Thymoma in myasthenia gravis: from diagnosis to treatment","volume":"2011","author":"Romi","year":"2011","journal-title":"Autoimmune Dis"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0580","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1056\/NEJM198707163170314","article-title":"Antibodies against the acetylcholine receptor in hematologic disorders: implications for the development of myasthenia gravis after bone marrow grafting","volume":"317","author":"Lefvert","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0585","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1097\/00007890-200104270-00026","article-title":"Guillain-Barr\u00e9 syndrome in organ and bone marrow transplant patients","volume":"71","author":"Bulsara","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2016.09.022","article-title":"Guillain-Barr\u00e9 syndrome","author":"Esposito","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0595","first-page":"10","article-title":"Guillain-Barr\u00e9 syndrome: pathological connection with GvHD after allogeneic bone marrow transplantation","volume":"11","author":"Nasilowska-Adamska","year":"2006","journal-title":"Ann Transplant"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0600","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/bmt.2008.81","article-title":"Rituximab-responsive Guillain-Barr\u00e9 syndrome following allogeneic hematopoietic SCT","volume":"42","author":"Ostronoff","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0605","first-page":"411","article-title":"Exacerbation of inflammatory demyelinating polyneuropathy after bone marrow transplantation","volume":"7","author":"Openshaw","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0610","series-title":"Chronic graft-versus-host disease: interdisciplinary management","first-page":"243","article-title":"Neurological manifestations of chronic graft versus host disease","author":"Openshaw","year":"2009"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0615","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1093\/brain\/awq245","article-title":"Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in Chronic Graft-versus-Host Disease","volume":"133","author":"Grauer","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0620","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/bmt.2009.323","article-title":"Cerebral angiitis in four patients with chronic GVHD","volume":"45","author":"Sostak","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0625","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.2169\/internalmedicine.48.2003","article-title":"Encephalomyelitis mimicking multiple sclerosis associated with chronic graft-versus-host disease after allogeneic bone marrow transplantation","volume":"48","author":"Matsuo","year":"2009","journal-title":"Intern Med"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0630","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1182\/blood-2014-05-552729","article-title":"Current concepts in the diagnosis and management of cytokine release syndrome","volume":"124","author":"Lee","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0635","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.bbmt.2016.06.010","article-title":"Severe cytokine-release syndrome after T cell-replete peripheral blood haploidentical donor transplantation is associated with poor survival and anti-IL-6 therapy is safe and well tolerated","volume":"22","author":"Abboud","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0640","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1200\/JCO.2014.56.2025","article-title":"Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor","volume":"33","author":"Kochenderfer","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0645","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0140-6736(14)61403-3","article-title":"T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial","volume":"385","author":"Lee","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0650","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.blre.2014.11.001","article-title":"A new paradigm: diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury","volume":"29","author":"Jodele","year":"2015","journal-title":"Blood Rev"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0655","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1182\/blood-2011-02-321315","article-title":"Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy","volume":"118","author":"Laskin","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0660","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1182\/blood-2013-05-501445","article-title":"Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy","volume":"122","author":"Jodele","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0665","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/01.tp.0000230373.82376.46","article-title":"Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation","volume":"82","author":"Uderzo","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0670","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/trf.12859","article-title":"Hematopoietic stem cell transplant-associated thrombotic microangiopathy: review of pharmacologic treatment options","volume":"55","author":"Kim","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0675","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1097\/TP.0000000000000601","article-title":"Use of Eculizumab in patients with allogeneic stem cell transplant-associated thrombotic microangiopathy: a study from the SFGM-TC","volume":"99","author":"de Fontbrune","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0680","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1365-2141.2007.06588.x","article-title":"Successful treatment of thrombotic microangiopathy after haematopoietic stem cell transplantation with rituximab","volume":"137","author":"Au","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0685","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1182\/blood.V72.2.520.520","article-title":"Epstein-Barr virus lymphoproliferation after bone marrow transplantation","volume":"72","author":"Zutter","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0690","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1182\/blood-2005-01-0377","article-title":"Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study","volume":"107","author":"Choquet","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0695","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.critrevonc.2010.07.005","article-title":"Intrathecal chemotherapy in lymphomatous meningitis","volume":"79","author":"Canova","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0700","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood-2009-08-239186","article-title":"Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients","volume":"115","author":"Heslop","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.12.632_bib0705","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/petr.12276","article-title":"Efficacy of prophylactic cranial irradiation and intrathecal chemotherapy for the prevention of CNS relapse after allogeneic hematopoietic SCT for childhood ALL","volume":"18","author":"Fukano","year":"2014","journal-title":"Pediatr Transplant"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879116311910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879116311910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:57:39Z","timestamp":1761058659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879116311910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":140,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S1083879116311910"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2016.12.632","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurologic Complications after Allogeneic Hematopoietic Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2016.12.632","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}